Medication info

Ospomine Tablets (Metformin Hydrochloride)

Prescription medicationTabletExpired
Ingredient · strength
Metformin Hydrochloride›500mg / 1 tablet
Manufacturer / importer
Os Korea Pharmaceutical Co., Ltd.
Appearance
White round film-coated tablets
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Expired

MFDS item code 201501723 · Approved 2015.03.31

This product's status changed to Expired on 2025.03.31. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of type 2 diabetes
Who uses it
Adults · Children
Adult dosage
The dose should be determined individually based on drug response and tolerability, and should not exceed the recommended maximum daily dose. This medicine must be initiated at a low dose to reduce gastrointestinal adverse reactions and identify the minimum dose required for adequate glycemic control. Administer 500mg 2~3 times daily with meals. Increase the dose gradually by 500mg each week. When administering up to 2000mg, the dose is usually divided into 2 doses daily, in the morning and evening. For doses exceeding 2000mg, divide the dose into 3 doses daily and administer with meals; the maximum daily dose is 2550mg. At initiation and during dose adjustment, measure fasting blood glucose to assess the response to treatment and identify the minimum effective dose. Glycated hemoglobin levels should be measured at approximately 3-month intervals. The goal of treatment with this medicine, whether used as monotherapy or in combination with a sulfonylurea or insulin, is to reduce fasting blood glucose and glycated hemoglobin to normal or near-normal levels using the minimum effective dose. In general, when blood glucose is temporarily uncontrolled in a patient whose levels were controlled by diet alone, a short course of this medicine may be sufficient to achieve an adequate effect. This medicine may be used in patients with moderate stage 3a renal impairment (creatinine clearance [CrCl] 45≤~<60ml/min or glomerular filtration rate (GFR) 45≤~<60mL/min/1.73㎡) who have no other condition that may increase the risk of lactic acidosis, with the following dose adjustment. - The initial dose is 500mg or 850mg once daily. The maximum daily dose is 1000mg, administered in 2 divided doses. Renal function should be monitored closely every 3-6 months. If creatinine clearance or glomerular filtration rate falls below 45ml/min or 45ml/min/1.73㎡, respectively, this medicine must be discontinued immediately.
Children's dosage
Children aged 10 years or older or adolescents who are growing: The usual initial dose is 500 milligrams once daily, administered during or after a meal. Blood glucose levels should be measured after one week and the dose adjusted. Gastrointestinal adverse effects may improve with gradual dose increases. The maximum daily dose is 2000mg. This dose should be divided into 2~3 doses.

Ingredients

Manufacturer
Os Korea Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of type 2 diabetes

  • Type 2 diabetes with insufficient blood sugar control
  • overweight
View approved original text

This medication is used for the treatment of patients with type 2 diabetes for whom dietary management and exercise alone are not sufficient for blood sugar control. It is particularly effective for adult patients who are overweight. This medication can be used alone or in conjunction with other oral hypoglycemic agents or insulin. It can also be used in children aged 10 years and older and adolescents during growth phases either as monotherapy or in combination with insulin. Therefore, it helps improve blood sugar control in patients with type 2 diabetes across various age groups.

Dosage and Administration

Adult dosage

The dose should be determined individually based on drug response and tolerability, and should not exceed the recommended maximum daily dose. This medicine must be initiated at a low dose to reduce gastrointestinal adverse reactions and identify the minimum dose required for adequate glycemic control. Administer 500mg 2~3 times daily with meals. Increase the dose gradually by 500mg each week. When administering up to 2000mg, the dose is usually divided into 2 doses daily, in the morning and evening. For doses exceeding 2000mg, divide the dose into 3 doses daily and administer with meals; the maximum daily dose is 2550mg. At initiation and during dose adjustment, measure fasting blood glucose to assess the response to treatment and identify the minimum effective dose. Glycated hemoglobin levels should be measured at approximately 3-month intervals. The goal of treatment with this medicine, whether used as monotherapy or in combination with a sulfonylurea or insulin, is to reduce fasting blood glucose and glycated hemoglobin to normal or near-normal levels using the minimum effective dose. In general, when blood glucose is temporarily uncontrolled in a patient whose levels were controlled by diet alone, a short course of this medicine may be sufficient to achieve an adequate effect. This medicine may be used in patients with moderate stage 3a renal impairment (creatinine clearance [CrCl] 45≤~<60ml/min or glomerular filtration rate (GFR) 45≤~<60mL/min/1.73㎡) who have no other condition that may increase the risk of lactic acidosis, with the following dose adjustment. - The initial dose is 500mg or 850mg once daily. The maximum daily dose is 1000mg, administered in 2 divided doses. Renal function should be monitored closely every 3-6 months. If creatinine clearance or glomerular filtration rate falls below 45ml/min or 45ml/min/1.73㎡, respectively, this medicine must be discontinued immediately.

Children's dosage

Children aged 10 years or older or adolescents who are growing: The usual initial dose is 500 milligrams once daily, administered during or after a meal. Blood glucose levels should be measured after one week and the dose adjusted. Gastrointestinal adverse effects may improve with gradual dose increases. The maximum daily dose is 2000mg. This dose should be divided into 2~3 doses.

Precautions

This medication can cause severe lactic acidosis or hypoglycemia and should be used with caution. It should not be administered to patients with moderate to severe impairment of renal function or those in acute conditions such as dehydration, severe infections, and cardiovascular collapse. It should also be avoided in patients with acute and unstable heart failure or those undergoing tests with radiopaque iodine contrast agents. Patients allergic to this medication or biguanide medications, as well as those with type 1 diabetes or metabolic acidosis, should not use this medication. For patients with serious infections, trauma, or undergoing surgery, the administration of this medication should be temporarily suspended and resumed only after the patient's condition improves. It should be administered with caution in malnourished states, starvation, debility, liver impairment, pulmonary impairment, or excessive alcohol consumption. This medication can cause a serious side effect known as lactic acidosis, which can be fatal; therefore, symptoms must be reported to a doctor immediately. Common gastrointestinal side effects include diarrhea, nausea, and vomiting; these symptoms generally improve naturally over time. While this medication lowers blood sugar, the risk of hypoglycemia may increase when taken with other hypoglycemic agents or alcohol, so caution is required. Regular kidney function tests should be conducted, and if kidney function declines, the medication should be discontinued or the dosage adjusted. Alcohol intake can affect lactate metabolism and increase the risk of lactic acidosis, so excessive drinking should be avoided while on this medication. No adverse effects on the fetus have been reported during pregnancy, but if there are risks of placental insufficiency or preeclampsia, administration should be avoided and fetal development should be closely monitored. During breastfeeding, as this medication may be secreted in breast milk, careful consideration of breastfeeding and medication treatment should be undertaken. Elderly patients often have declining kidney function, so dosing adjustments and regular kidney function monitoring are essential. There are several medications that interact with this drug, so consultation with a doctor or pharmacist is advisable if other medications are being taken. In case of overdose, the medication can be removed through hemodialysis, so care must be taken not to exceed the recommended dosage. This medication does not cause weight gain, which may be beneficial for diabetic patients needing weight management. When administered to children or adolescents, growth and development should be monitored closely.

Side effects

  • Lactic acidosis
  • diarrhea
  • nausea
  • vomiting
  • abdominal bloating
  • loss of appetite
  • indigestion
  • constipation
  • abdominal pain
  • unpleasant metallic taste
Show 7 more
  • rash
  • anemia
  • leukopenia
  • thrombocytopenia
  • vitamin B12 deficiency
  • abnormal liver function
  • hypoglycemia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture. The recommended storage temperature is between 1 and 30 degrees Celsius at room temperature. Proper storage will ensure the safe maintenance of the medication's efficacy.

Appearance and packaging

Appearance

White round film-coated tablets

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.